2,485
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest

, , , , &
Pages 258-269 | Published online: 20 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Chiara Selmi & Antonio La Marca. (2023) Oral hormonal therapy as treatment option for abnormal uterine bleeding. The European Journal of Contraception & Reproductive Health Care 28:6, pages 285-294.
Read now
Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Ioannis Tsakiridis, Sonia Giouleka, Georgia Koutsouki, Nikolaos Kostakis, Ioannis Kalogiannidis, Anargyros Kourtis, Apostolos Athanasiadis, Dimitrios G. Goulis & Themistoklis Dagklis. (2022) Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations. The European Journal of Contraception & Reproductive Health Care 27:6, pages 504-517.
Read now
Salvatore Giovanni Vitale, Gaetano Riemma, Luis Alonso Pacheco, Jose Carugno, Sergio Haimovich, Jan Tesarik, Maria Chiara De Angelis, Attilio Di Spiezio Sardo & Pasquale De Franciscis. (2021) Hysteroscopic endometrial biopsy: from indications to instrumentation and techniques. A call to action. Minimally Invasive Therapy & Allied Technologies 30:5, pages 251-262.
Read now
A. L. da Silva Filho, C. Caetano, A. Lahav, G. Grandi & R. M. Lamaita. (2021) The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey. The European Journal of Contraception & Reproductive Health Care 26:5, pages 390-398.
Read now
Alessandra Graziottin. (2016) The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval. The European Journal of Contraception & Reproductive Health Care 21:2, pages 93-105.
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Rossella E Nappi, Marco Serrani & Jeffrey T Jensen. (2014) Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. International Journal of Women's Health 6, pages 711-718.
Read now
Jeffrey T Jensen, Johannes Bitzer & Marco Serrani. (2013) Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol. Open Access Journal of Contraception 4, pages 39-50.
Read now
Johannes Bitzer, Marco Serrani & Annalena Lahav. (2013) Women's attitudes towards heavy menstrual bleeding, and their impact on quality of life. Open Access Journal of Contraception 4, pages 21-28.
Read now
Sally Rafie, Laura Borgelt, Erin R Koepf, Mary E Temple-Cooper & K Joy Lehman. (2013) Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest. International Journal of Women's Health 5, pages 313-321.
Read now
Thierry G Vancaillie. (2013) Emerging trends in female permanent contraception. Expert Review of Obstetrics & Gynecology 8:3, pages 285-294.
Read now
Franca Fruzzetti, Florence Trémollieres & Johannes Bitzer. (2012) An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest. Gynecological Endocrinology 28:5, pages 400-408.
Read now
Ying Su, Qing-Quan Lian & Ren-Shan Ge. (2012) Contraceptives with novel benefits. Expert Opinion on Investigational Drugs 21:1, pages 83-90.
Read now

Articles from other publishers (38)

Neha Pandey, Sudarsan Desul, Raj Kishore Patra & Mrutyunjay Sethy. (2023) Menstrual health and hygiene (MHH): a bibliometric analysis. Global Knowledge, Memory and Communication.
Crossref
L.I. Maltseva & Yu.V. Garifullova. (2023) Long-term contraception with combined hormonal drugs until menopause. Benefits and risks. Problemy reproduktsii 29:5, pages 102.
Crossref
Jacques Donnez, Hugh S Taylor, Elizabeth A Stewart, Linda Bradley, Erica Marsh, David Archer, Ayman Al-Hendy, Felice Petraglia, Nelson Watts, Jean-Pierre Gotteland, Elke Bestel, Paul Terrill, Ernest Loumaye, Andrew Humberstone & Elizabeth Garner. (2022) Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. The Lancet 400:10356, pages 896-907.
Crossref
Galina E. Chernukha. (2022) Relevance of abnormal uterine bleeding issue in young women and its comprehensive solution considering 2021 Russian Guidelines. Gynecology 24:3, pages 198-205.
Crossref
Rohan R. Chodankar, Malcolm G. Munro & Hilary O. D. Critchley. (2022) Historical Perspectives and Evolution of Menstrual Terminology. Frontiers in Reproductive Health 4.
Crossref
Melvin E. Andersen, Pankajini Mallick, Harvey J. ClewellIIIIII, Miyoung Yoon, Geary W. Olsen & Matthew P. Longnecker. (2021) Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures. Environmental Research 197, pages 111183.
Crossref
Renato Seracchioli, Simona Del Forno & Eugenia Degli Esposti. 2021. Female and Male Contraception. Female and Male Contraception 135 160 .
Michael Laffan, Jameela Sathar & Jill M. Johnsen. (2020) von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis. Haemophilia.
Crossref
Galina B. Dikke. (2020) Needs, expectations and doubt users of hormonal contraceptives. Gynecology 22:1, pages 33-37.
Crossref
V.N. Kasyan. (2020) Standard counseling for the choice of hormonal contraceptive for safe long-term use (literature review). Problemy reproduktsii 26:2, pages 87.
Crossref
Raj Narayan & Benjamin D. Beran. 2020. Sex- and Gender-Based Women's Health. Sex- and Gender-Based Women's Health 99 116 .
Ю. Г. Антипкін, Ю. П. Вдовиченко, А. Грациоттін, В. В. Камінський, Т. Ф. Татарчук, О. В. Булавенко, О. В. Грищенко, З. М. Дубоссарська, Ю. О. Дубоссарська, Н. Я. Жилка, Г. В. Зайченко, В. П. Квашенко, Н. В. Косей, О. М. Макарчук, Н. Ю. Педаченко, В. І. Пирогова & Н. М. Рожковська. (2019) Uterine bleedings and quality of woman's life. Reproductive Endocrinology 0:47, pages 8-12.
Crossref
G. В. Dikke. (2019) Therapeutic tactics in abnormal uterine bleeding without anatomical substrate. Medical Council:21, pages 168-172.
Crossref
Rezan KadirJoanna S. Davies & Rezan A. Kadir. 2019. Inherited Bleeding Disorders in Women 2e. Inherited Bleeding Disorders in Women 2e 45 64 .
Bruce R. Carr, Elizabeth A. Stewart, David F. Archer, Ayman Al-Hendy, Linda Bradley, Nelson B. Watts, Michael P. Diamond, Jingjing Gao, Charlotte D. Owens, Kristof Chwalisz, W. Rachel Duan, Ahmed M. Soliman, Matthew B. Dufek & James A. Simon. (2018) Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstetrics & Gynecology 132:5, pages 1252-1264.
Crossref
Roger P. SmithRoger P. Smith. 2018. Dysmenorrhea and Menorrhagia. Dysmenorrhea and Menorrhagia 135 147 .
Intira Sriprasert, Tarita Pakrashi, Thomas Kimble & David F. Archer. (2017) Heavy menstrual bleeding diagnosis and medical management. Contraception and Reproductive Medicine 2:1.
Crossref
Catherine Olubummo. (2017) Severe Uterine Bleeding. POJ Gynaecology & Obstetrics Research 1:1, pages 1-4.
Crossref
Joanna Davies & Rezan A. Kadir. (2017) Heavy menstrual bleeding: An update on management. Thrombosis Research 151, pages S70-S77.
Crossref
Jeong Sook Kim & Sihyun Cho. (2017) Clinical use of oral contraceptives. Journal of the Korean Medical Association 60:8, pages 687.
Crossref
G. B. Dikke. (2017) Failure from the previously selected method of contraception and strategy for improving commitment. Problemy reproduktsii 23:5, pages 54.
Crossref
Luis Bahamondes, Victor Marin, Silvia Ciarmatori, Agnaldo L. Silva-Filho, Juan Manuel Acuña & Maria Y. Makuch. (2016) Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding. Obstetrics and Gynecology International 2016, pages 1-6.
Crossref
Luis Bahamondes, M. Valeria Bahamondes & Lee P. Shulman. (2015) Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Human Reproduction Update 21:5, pages 640-651.
Crossref
Iñaki Lete, Ignacio Cristóbal, Ignacio Canals, Carlos Crespo, Belén Espinós & Joaquín Calaf. (2015) Evaluación económica de los tratamientos orales para el sangrado menstrual abundante en España. PharmacoEconomics Spanish Research Articles 12:3, pages 105-114.
Crossref
Johannes Bitzer, Oskari Heikinheimo, Anita L. Nelson, Joaquin Calaf-Alsina & Ian S. Fraser. (2015) Medical Management of Heavy Menstrual Bleeding. Obstetrical & Gynecological Survey 70:2, pages 115-130.
Crossref
E. N. Andreeva. (2015) Heavy menstrual bleeding: modern approach to problem solution. Problemy reproduktsii 21:6, pages 47.
Crossref
J. Calaf, I. Lete, I. Canals, C. Crespo, B. Espinós & I. Cristóbal. (2015) Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain. European Journal of Obstetrics & Gynecology and Reproductive Biology 184, pages 24-31.
Crossref
Julie Craik & Louise Melvin. 2015. Medicines For Women. Medicines For Women 141 180 .
Mayank Madhra, Ian S. Fraser, Malcolm G. Munro & Hilary O. D. Critchley. (2014) Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstetricia et Gynecologica Scandinavica 93:7, pages 619-625.
Crossref
Kristina Tocce & S. Lindsey Davis. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient 181 204 .
Kristina Tocce & S. Lindsey Davis. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient 181 204 .
D. Foth, T. Römer & H.-J. Ahrendt. (2013) Hormonelle Kontrazeption mit östradiolhaltigen KombinationspräparatenHormonal contraception with estradiol-containing combined preparations. Gynäkologische Endokrinologie 11:3, pages 162-167.
Crossref
Ian S. Fraser, Susan Zeun, Susanne Parke, Baerbel Wilke, Wolfgang Junge & Marco Serrani. (2013) Improving the Objective Quality of Large-Scale Clinical Trials for Women With Heavy Menstrual Bleeding: Experience from 2 Multi-Center, Randomized Trials. Reproductive Sciences 20:7, pages 745-754.
Crossref
Hatem Abu Hashim. (2012) Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach. Archives of Gynecology and Obstetrics 287:2, pages 251-260.
Crossref
M. Hickey & I. S. Fraser. (2012) Iatrogenic unscheduled (breakthrough) endometrial bleeding. Reviews in Endocrine and Metabolic Disorders 13:4, pages 301-308.
Crossref
Ian S. Fraser, Jeffrey Jensen, Matthias Schaefers, Uwe Mellinger, Susanne Parke & Marco Serrani. (2012) Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest. Contraception 86:2, pages 96-101.
Crossref
Xiangyan Ruan, H. Seeger & A.O. Mueck. (2012) The pharmacology of dienogest. Maturitas 71:4, pages 337-344.
Crossref
I. S. Fraser, T. Romer, S. Parke, S. Zeun, U. Mellinger, A. Machlitt & J. T. Jensen. (2011) Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial. Human Reproduction 26:10, pages 2698-2708.
Crossref